Drug intelligence / Profile preview

dingkundan + ethinylestradiol + cyproterone acetate

Development stage
Unknown
Lead developer
Guangyuyuan
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination product containing three active ingredients: Dingkundan, ethinylestradiol, and cyproterone acetate. Ethinylestradiol is a synthetic estrogen, and cyproterone acetate is a synthetic progestogen with anti-androgenic properties. The combination of ethinylestradiol and cyproterone acetate is widely used to treat androgen-dependent conditions in women such as severe acne, seborrhea (oily skin), hirsutism (excessive hair growth), and sometimes for contraception in women who require treatment for these conditions[1][3][4][5][6][7]. Cyproterone acetate acts by blocking androgen receptors and suppressing ovarian androgen production, while ethinylestradiol increases sex hormone–binding globulin to reduce free circulating androgens[5]. Dingkundan appears to be an additional component; however, there is no widely recognized pharmaceutical or clinical information about "Dingkundan" as an established drug or supplement in major international databases. Therefore, the mechanism of action or therapeutic role of Dingkundan within this combination cannot be determined from available sources.

02

Targets

PR (Progesterone receptor)ER (Estrogen receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on dingkundan + ethinylestradiol + cyproterone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dingkundan + ethinylestradiol + cyproterone acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call